Sunday, 4 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Latest announcements

Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.

14:33 IST NSE
Other AnnouncementTBO Tek Ltd TBOTEK

TBO Tek Other Announcement

TBO Tek Limited notified shareholders about the dispatch of letters regarding its FY 2025-26 Annual Report and 20th AGM notice. The document provides web-links and QR codes for digital access.

14:34 IST BSE
New Order WinGabion Technologies India Ltd 544675

Gabion Technologies India Bags ₹5.42 Cr Order

Gabion Technologies India Limited secured multiple work and supply orders totaling ₹5.42 Crore. The orders involve domestic and export supply of gabion products and slope protection works.

Value
₹5.42 Cr
Execution
Various periods ranging from immediate delivery to September 30, 2026
14:33 IST BSE
Board Meeting DateCatvision Ltd CATVISION

Catvision Board Meeting Date

Catvision Limited has scheduled a board meeting for August 13, 2026. The board will consider and approve the unaudited standalone and consolidated financial results for the June quarter.

14:33 IST NSE
Financial ResultsDhunseri Ventures Ltd DVL

Dhunseri Ventures Q1 FY27 Results: Net Profit ₹174.3 Cr, Up 146.2% YoY

Dhunseri Ventures Ltd reported revenue from operations of ₹231.6 Cr (+44.8% YoY) and net profit of ₹174.3 Cr (+146.2% YoY) for Q1 FY27.

Key figure
Net profit ₹174.3 Cr · +146.2% YoY
14:28 IST BSE
Fund RaiseBharat Forge Ltd BHARATFORG

Bharat Forge Fund Raise

Bharat Forge Limited's board has approved a fund-raising proposal on August 10, 2026. An Investment Committee will determine the issuance structure, pricing, and timing for the capital raise.

12:54 IST BSE
Earnings CallAlembic Pharmaceuticals Ltd APLLTD

Alembic Pharmaceuticals Investor Presentation: Key Takeaways

Q1FY27 revenue grew 26% to INR 2,150 Cr. Strategy focuses on US Generics volume growth, India Specialty therapeutic scale-up, and managing margin dilution from US branded investments.

Call
Guides 15% growth